MEIHUA INTERNATIONAL MEDICAL (MHUA)
KYG5966G1082 - Common Stock
Overall MHUA gets a fundamental rating of 5 out of 10. We evaluated MHUA against 191 industry peers in the Health Care Equipment & Supplies industry. MHUA has an excellent financial health rating, but there are some minor concerns on its profitability. MHUA is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year MHUA was profitable.
In the past year MHUA had a positive cash flow from operations.
Each year in the past 5 years MHUA has been profitable.
In multiple years MHUA reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of MHUA (9.12%) is better than 91.01% of its industry peers.
MHUA's Return On Equity of 10.93% is amongst the best of the industry. MHUA outperforms 85.19% of its industry peers.
MHUA's Return On Invested Capital of 8.53% is amongst the best of the industry. MHUA outperforms 87.83% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MHUA is in line with the industry average of 8.08%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 10.93% | ||
| ROIC | 8.53% |
ROA(3y)8.61%
ROA(5y)12.96%
ROE(3y)10.61%
ROE(5y)16.01%
ROIC(3y)8.98%
ROIC(5y)13.13%
1.3 Margins
MHUA has a Profit Margin of 11.47%. This is amongst the best in the industry. MHUA outperforms 87.83% of its industry peers.
In the last couple of years the Profit Margin of MHUA has declined.
Looking at the Operating Margin, with a value of 14.44%, MHUA belongs to the top of the industry, outperforming 84.13% of the companies in the same industry.
MHUA's Operating Margin has declined in the last couple of years.
MHUA has a worse Gross Margin (33.97%) than 70.90% of its industry peers.
MHUA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.44% | ||
| PM (TTM) | 11.47% | ||
| GM | 33.97% |
OM growth 3Y-16.94%
OM growth 5Y-9.84%
PM growth 3Y-17.5%
PM growth 5Y-10.18%
GM growth 3Y-6.44%
GM growth 5Y-4.15%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MHUA is creating some value.
The number of shares outstanding for MHUA remains at a similar level compared to 1 year ago.
Compared to 5 years ago, MHUA has more shares outstanding
The debt/assets ratio for MHUA is higher compared to a year ago.
2.2 Solvency
MHUA has an Altman-Z score of 3.03. This indicates that MHUA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.03, MHUA is doing good in the industry, outperforming 67.72% of the companies in the same industry.
The Debt to FCF ratio of MHUA is 1.37, which is an excellent value as it means it would take MHUA, only 1.37 years of fcf income to pay off all of its debts.
MHUA's Debt to FCF ratio of 1.37 is amongst the best of the industry. MHUA outperforms 89.42% of its industry peers.
MHUA has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
MHUA has a better Debt to Equity ratio (0.08) than 60.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.37 | ||
| Altman-Z | 3.03 |
ROIC/WACC1.33
WACC6.4%
2.3 Liquidity
A Current Ratio of 4.78 indicates that MHUA has no problem at all paying its short term obligations.
MHUA has a better Current ratio (4.78) than 76.72% of its industry peers.
A Quick Ratio of 4.74 indicates that MHUA has no problem at all paying its short term obligations.
MHUA's Quick ratio of 4.74 is fine compared to the rest of the industry. MHUA outperforms 79.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.78 | ||
| Quick Ratio | 4.74 |
3. Growth
3.1 Past
MHUA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.80%, which is quite good.
The Earnings Per Share has been decreasing by -8.81% on average over the past years.
The Revenue has decreased by -6.00% in the past year.
MHUA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.11% yearly.
EPS 1Y (TTM)13.8%
EPS 3Y-20.04%
EPS 5Y-8.81%
EPS Q2Q%-47.95%
Revenue 1Y (TTM)-6%
Revenue growth 3Y2.91%
Revenue growth 5Y5.11%
Sales Q2Q%-5.91%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
MHUA is valuated cheaply with a Price/Earnings ratio of 0.49.
MHUA's Price/Earnings ratio is rather cheap when compared to the industry. MHUA is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.28. MHUA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.49 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MHUA indicates a rather cheap valuation: MHUA is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.17 | ||
| EV/EBITDA | -0.4 |
4.3 Compensation for Growth
MHUA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for MHUA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MEIHUA INTERNATIONAL MEDICAL
NASDAQ:MHUA (1/15/2025, 1:59:13 PM)
0.3145
0 (-0.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners2.53%
Inst Owner Change0%
Ins Owners56.48%
Ins Owner ChangeN/A
Market Cap10.03M
AnalystsN/A
Price TargetN/A
Short Float %0.57%
Short Ratio0.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.49 | ||
| Fwd PE | N/A | ||
| P/S | 0.07 | ||
| P/FCF | 1.17 | ||
| P/OCF | 1.15 | ||
| P/B | 0.07 | ||
| P/tB | 0.07 | ||
| EV/EBITDA | -0.4 |
EPS(TTM)0.64
EY203.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.27
FCFY85.67%
OCF(TTM)0.27
OCFY86.83%
SpS4.47
BVpS4.69
TBVpS4.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 10.93% | ||
| ROCE | 13.75% | ||
| ROIC | 8.53% | ||
| ROICexc | 9.64% | ||
| ROICexgc | 9.67% | ||
| OM | 14.44% | ||
| PM (TTM) | 11.47% | ||
| GM | 33.97% | ||
| FCFM | 6.03% |
ROA(3y)8.61%
ROA(5y)12.96%
ROE(3y)10.61%
ROE(5y)16.01%
ROIC(3y)8.98%
ROIC(5y)13.13%
ROICexc(3y)10.01%
ROICexc(5y)15.52%
ROICexgc(3y)10.12%
ROICexgc(5y)15.69%
ROCE(3y)14.05%
ROCE(5y)20.48%
ROICexcg growth 3Y-27.88%
ROICexcg growth 5Y-29.21%
ROICexc growth 3Y-28.39%
ROICexc growth 5Y-29.35%
OM growth 3Y-16.94%
OM growth 5Y-9.84%
PM growth 3Y-17.5%
PM growth 5Y-10.18%
GM growth 3Y-6.44%
GM growth 5Y-4.15%
F-Score4
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.37 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 24.8% | ||
| Cap/Sales | 0.08% | ||
| Interest Coverage | 86.22 | ||
| Cash Conversion | 41.41% | ||
| Profit Quality | 52.59% | ||
| Current Ratio | 4.78 | ||
| Quick Ratio | 4.74 | ||
| Altman-Z | 3.03 |
F-Score4
WACC6.4%
ROIC/WACC1.33
Cap/Depr(3y)537.8%
Cap/Depr(5y)817.44%
Cap/Sales(3y)2.75%
Cap/Sales(5y)4.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.8%
EPS 3Y-20.04%
EPS 5Y-8.81%
EPS Q2Q%-47.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6%
Revenue growth 3Y2.91%
Revenue growth 5Y5.11%
Sales Q2Q%-5.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.36%
EBIT growth 3Y-14.53%
EBIT growth 5Y-5.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.84%
OCF growth 3Y-24.7%
OCF growth 5Y-28.07%